London School of Hygiene and Tropical Medicine

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1899-01-01

Employees: 1K

Market Cap: -

Website: http://www.lshtm.ac.uk

Clinical Trials

HIV Self-Testing Africa Zambia

Not Applicable

Completed

Conditions: HIV

Interventions: Device: Oraquick (made in Thailand)

First Posted Date: 2016-06-08

Last Posted Date: 2018-05-14

Lead Sponsor: London School of Hygiene and Tropical Medicine

Target Recruit Count: 5005

Registration Number: NCT02793804

Locations: 🇿🇲
Lusaka, Lusaka, Zambia

STATIN: Web-based Investigation of Side Effects

Phase 4

Completed

Conditions: Cardiovascular Disease

Interventions: Drug: Atorvastatin 20mg
Drug: Placebo

First Posted Date: 2016-05-24

Last Posted Date: 2019-08-16

Lead Sponsor: London School of Hygiene and Tropical Medicine

Target Recruit Count: 200

Registration Number: NCT02781064

Locations: 🇬🇧
Oak Lodge Medical Centre, Edgware, United Kingdom
🇬🇧
Queen Square Medical Practice, Lancaster, United Kingdom
🇬🇧
Bentley Surgery, Doncaster, United Kingdom

and more 55 locations

Azithromycin - Ivermectin Mass Drug Administration for Skin Disease

Phase 4

Completed

Conditions: Yaws
Impetigo
Scabies

Interventions: Drug: Ivermectin
Drug: Azithromycin
Drug: Permethrin

First Posted Date: 2016-05-17

Last Posted Date: 2019-09-17

Lead Sponsor: London School of Hygiene and Tropical Medicine

Target Recruit Count: 1291

Registration Number: NCT02775617

Locations: 🇸🇧
Atoifi Adventist Hospital, Atoifi, Malaita, Solomon Islands

HIV Self-Testing Africa (STAR) Malawi: General Population

Not Applicable

Completed

Conditions: HIV

Interventions: Device: OraQuick ADVANCE HIV I/II test kits, packaged for self-use (manufactured in Thailand)
Other: Home-based initiation of ARVs

First Posted Date: 2016-03-24

Last Posted Date: 2018-05-14

Lead Sponsor: London School of Hygiene and Tropical Medicine

Target Recruit Count: 5504

Registration Number: NCT02718274

Feasibility of the Vapor Nanobubble Technology for Malaria Diagnostics (MalariaSense)

Not Applicable

Completed

Conditions: Malaria

Interventions: Device: MalariaSense device

First Posted Date: 2016-02-03

Last Posted Date: 2018-03-22

Lead Sponsor: London School of Hygiene and Tropical Medicine

Target Recruit Count: 208

Registration Number: NCT02672228

Locations: 🇬🇲
Basse Health Centre, Basse, Upper River Region, Gambia

Zinc Absorption From SQ-LNS With and Without Phytase

Not Applicable

Completed

Conditions: Individuals at Risk of Zinc Deficiency

Interventions: Dietary Supplement: the nutritional supplement to be used in this trial is a SQ-LNS
Dietary Supplement: lipid-based nutrient supplement (SQ-LNS) with phytase
Dietary Supplement: 0.9 mg isotopically enriched 67Zn,0.30 mg isotopically enriched 70Zn, 0.60 mg non-enriched zinc
Dietary Supplement: 1 mg isotopically enriched 68Zn

First Posted Date: 2016-01-29

Last Posted Date: 2018-03-22

Lead Sponsor: London School of Hygiene and Tropical Medicine

Target Recruit Count: 26

Registration Number: NCT02668133

Locations: 🇬🇲
Keneba Clinic, Kiang, Gambia

Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia

Phase 2

Terminated

Conditions: Malaria

Interventions: Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD deficient
Drug: Dihydroartemisinin-piperaquine (DHAP) administered to G6PD deficient
Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD deficient
Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD normal
Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD normal

First Posted Date: 2016-01-13

Last Posted Date: 2016-09-09

Lead Sponsor: London School of Hygiene and Tropical Medicine

Target Recruit Count: 61

Registration Number: NCT02654730

Locations: 🇬🇲
Medical Research Council Laboratories, Fajara, Gambia

Protecting From Pneumococcus in Early Life (The PROPEL Trial)

Phase 3

Conditions: Pneumonia

Interventions: Other: tetanus toxoid
Biological: placebo 0.9% sodium chloride plus tetanus toxoid
Biological: 13-valent pneumococcal conjugate vaccine [Prevenar13®] plus tetanus toxoid